Home > Field of Cooperation > Health Research > Accelerating Vaccine Development for Plasmodium Vivax Malaria
Accelerating Vaccine Development for Plasmodium Vivax Malaria |
| Principal Investigator / Affiliation | James Beeson (Deputy Director) / Burnet Institute  Australia |
|---|---|
Rintis Noviyanti (Senior Research Scientist) / National Research and Innovation Agency (BRIN)  Indonesia |
|
Eizo Takashima (Associate Professor) / Ehime University  Japan |
|
| Year Adopted | 2024 |
| Research Period | 3 years |
| General Description of the Research Project | A Plasmodium vivax malaria vaccine is crucial to elimination efforts in Asia-Pacific but remains elusive. This project will advance development of promising vaccine candidates identified as major targets of potent protective functional antibody activity. Lead antigens will undergo extensive evaluation in clinical studies of symptomatic malaria, identifying regions targeted by protective antibodies and not vulnerable to vaccine escape. This will inform optimal candidate design as mRNA vaccines using our established platforms supporting pre-clinical studies and development with industry partners. |
| Photo Gallery | |
| Reports | |
| Links |
Researchers
| Principal Investigator / Country of Research Team | 
James Beeson Australia
Rintis Noviyanti Indonesia
Eizo Takashima Japan |
|---|